SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-015882
Filing Date
2021-08-05
Accepted
2021-08-05 16:31:19
Documents
60
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ngm-20210630.htm   iXBRL 10-Q 1595871
2 EX-10.1 ngm-20210630x10qex101.htm EX-10.1 1385800
3 EX-10.2 ngm-20210630x10qex102.htm EX-10.2 42489
4 EX-31.1 ngm-20210630x10qex311.htm EX-31.1 10101
5 EX-31.2 ngm-20210630x10qex312.htm EX-31.2 10118
6 EX-32.1 ngm-20210630x10qex321.htm EX-32.1 7555
  Complete submission text file 0001628280-21-015882.txt   8024501

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngm-20210630.xsd EX-101.SCH 43079
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ngm-20210630_cal.xml EX-101.CAL 48678
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ngm-20210630_def.xml EX-101.DEF 161822
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngm-20210630_lab.xml EX-101.LAB 512438
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngm-20210630_pre.xml EX-101.PRE 314990
12 EXTRACTED XBRL INSTANCE DOCUMENT ngm-20210630_htm.xml XML 1089495
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38853 | Film No.: 211148814
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences